sodium alfendronate

Italy

Drugs containing this active substance

  • ALENDRONATE ACID ZENTIVA

    It is used to treat bone diseases in women after menopause, particularly to prevent postmenopausal osteoporosis and reduce the risk of spinal and hip fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • ALENDRONATE ALMUS

    This medicine is used to prevent the loss of bone tissue in women after menopause (osteoporosis) and to promote bone rebuilding, reducing the risk of hip and spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: ALMUS S.R.L.

  • ALENDRONATE AND COLECALCIFEROL DOC GENERICI

    This medicine is prescribed for the treatment of osteoporosis and to reduce the risk of vitamin D deficiency. In postmenopausal women, it helps to reduce the risk of vertebral and hip fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -
    cholecalciferol -

    ATC: M05BB03

    Manufacturer: DOC GENERICI SRL

  • ALENDRONATE DOC GENERICI

    It is prescribed for the treatment of osteoporosis in postmenopausal women. It is used to prevent the loss of bone tissue, promote bone rebuilding, and reduce the risk of spinal and hip fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: DOC GENERICI SRL

  • ALENDRONATE MYLAN GENERICS

    It is used to treat osteoporosis in post-menopausal women, helping to reduce the risk of hip or vertebral fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: MYLAN S.P.A.

  • ALENDRONATE PHARMACARE

    It is prescribed for the treatment of osteoporosis in postmenopausal women. It is used to prevent the loss of bone tissue, promote bone rebuilding, and reduce the risk of hip and spinal fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: PHARMACARE S.R.L.

  • ALENDRONATE TEVA

    This medicine is prescribed to treat osteoporosis. It is used to prevent the loss of bone mass in women during and after menopause and helps to rebuild bone, reducing the risk of spinal and hip fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: TEVA B.V.

  • ALENIC

    Alenic is prescribed for the treatment of osteoporosis in postmenopausal women. The drug helps prevent the loss of bone tissue, promotes bone rebuilding, and reduces the risk of hip and spinal fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: EPIFARMA S.R.L

  • ASTON

    This medicine is prescribed for the treatment of osteoporosis in women after menopause. It is used to prevent the loss of bone tissue, promote bone rebuilding, and reduce the risk of hip and spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: S.F. GROUP S.R.L.

  • DRALENOS

    Dralenos is used to treat osteoporosis in postmenopausal women, preventing the thinning and weakening of bones. It can also be used to treat and prevent osteoporosis in patients at risk of bone loss who are taking long-term steroids.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: I.B.N. SAVIO S.R.L

  • FOSAVANCE

    It is prescribed for the treatment of osteoporosis and to reduce the risk of vitamin D deficiency. In postmenopausal women, it helps to reduce the risk of spinal and hip fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -
    cholecalciferol -

    ATC: M05BB03

    Manufacturer: N.V. ORGANON

  • GLAMOR

    This medicinal product is used for the treatment of osteoporosis and bone diseases. It is used to prevent the loss of bone tissue in women after menopause and to promote bone rebuilding, reducing the risk of hip and spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: A.G.I.P.S. FARMACEUTICI SRL

  • PORODRON

    Porodron is prescribed for the treatment of osteoporosis. The drug helps prevent the loss of bone tissue in postmenopausal women, promotes bone rebuilding, and reduces the risk of hip and spinal fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: DYMALIFE PHARMACEUTICAL S.R.L.

  • PORONAL

    This medicine is prescribed for the treatment of osteoporosis. It is used to prevent the loss of bone tissue in women after menopause and to reduce the risk of fractures in the hip and spine.

    Form: tablets, film-coated

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: KONPHARMA S.R.L.

  • REALEN

    REALEN is prescribed for the treatment of osteoporosis in postmenopausal women. It is used to prevent the loss of bone tissue and to reduce the risk of hip and spinal fractures.

    Form: tablets, film-coated

    Active substance Dosage
    sodium alfendronate -

    ATC: M05BA04

    Manufacturer: S.F. GROUP S.R.L.

  • VANTAVO

    VANTAVO is prescribed for the treatment of osteoporosis and to reduce the risk of vitamin D deficiency. In postmenopausal women, it helps to reduce the risk of spinal and hip fractures.

    Form: tablets

    Active substance Dosage
    sodium alfendronate -
    cholecalciferol -

    ATC: M05BB03

    Manufacturer: N.V. ORGANON